{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["breast cancer", "drugs", "ferroptosis", "ferroptosis-inducing agents", "natural compounds"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37920209", "DateRevised": {"Year": "2023", "Month": "11", "Day": "04"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "10", "Day": "18"}], "Language": ["eng"], "ELocationID": ["1243286", "10.3389/fphar.2023.1243286"], "Journal": {"ISSN": "1663-9812", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2023"}}, "Title": "Frontiers in pharmacology", "ISOAbbreviation": "Front Pharmacol"}, "ArticleTitle": "Compounds targeting ferroptosis in breast cancer: progress and their therapeutic potential.", "Pagination": {"StartPage": "1243286", "MedlinePgn": "1243286"}, "Abstract": {"AbstractText": ["In recent years, there has been a significant increase in the incidence of Breast cancer (BC), making it the most common cancer among women and a major threat to women's health. Consequently, there is an urgent need to discover new and effective strategies for treating BC. Ferroptosis, a novel form of cell death characterized by the accumulation of iron-dependent lipid reactive oxygen species, has emerged as a distinct regulatory pathway separate from necrosis, apoptosis, and autophagy. It is widely recognized as a crucial factor in the development and progression of cancer, offering a promising avenue for BC treatment. While significant progress has been made in understanding the mechanisms of ferroptosis in BC, drug development is still in its early stages. Numerous compounds, including phytochemicals derived from dietary sources and medicinal plants, as well as synthetic drugs (both clinically approved medications and laboratory reagents), have shown the ability to induce ferroptosis in BC cells, effectively inhibiting tumor growth. This comprehensive review aims to examine in detail the compounds that target ferroptosis in BC and elucidate their potential mechanisms of action. Additionally, the challenges associated with the clinical application of ferroptosis-inducing drugs are discussed, offering valuable insights for the development of novel treatment strategies for BC."], "CopyrightInformation": "Copyright \u00a9 2023 Xu, Chen, Yu, Song, Jin and Gao."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang, China."}], "LastName": "Xu", "ForeName": "Chuchu", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang, China."}], "LastName": "Chen", "ForeName": "Yian", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang, China."}], "LastName": "Yu", "ForeName": "Qinghong", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang, China."}], "LastName": "Song", "ForeName": "Jiaqing", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang, China."}], "LastName": "Jin", "ForeName": "Ying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The First Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China."}, {"Identifier": [], "Affiliation": "Department of Breast Surgery, The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine, Hangzhou, Zhejiang, China."}], "LastName": "Gao", "ForeName": "Xiufei", "Initials": "X"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Pharmacol", "NlmUniqueID": "101548923", "ISSNLinking": "1663-9812"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Akhtar M. F., Saleem A., Rasul A., Faran Ashraf Baig M. M., Bin-Jumah M., Abdel Daim M. M. (2020). Anticancer natural medicines: an overview of cell signaling and other targets of anticancer phytochemicals. Eur. J. Pharmacol. 888, 173488. 10.1016/j.ejphar.2020.173488", "ArticleIdList": ["10.1016/j.ejphar.2020.173488", "32805253"]}, {"Citation": "Al Zahrani N. A., El-Shishtawy R. M., Asiri A. M. (2020). Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: a review. Eur. J. Med. Chem. 204, 112609. 10.1016/j.ejmech.2020.112609", "ArticleIdList": ["10.1016/j.ejmech.2020.112609", "32731188"]}, {"Citation": "An S., Hu M. (2022). Quercetin promotes TFEB nuclear translocation and activates lysosomal degradation of ferritin to induce ferroptosis in breast cancer cells. Comput. Intell. Neurosci. 2022, 5299218. 10.1155/2022/5299218", "ArticleIdList": ["10.1155/2022/5299218", "PMC9313917", "35898781"]}, {"Citation": "Andrieu G., Belkina A. C., Denis G. V. (2016). Clinical trials for BET inhibitors run ahead of the science. Drug Discov. Today Technol. 19, 45\u201350. 10.1016/j.ddtec.2016.06.004", "ArticleIdList": ["10.1016/j.ddtec.2016.06.004", "PMC5116321", "27769357"]}, {"Citation": "Bak M. J., Das Gupta S., Wahler J., Suh N. (2016). Role of dietary bioactive natural products in estrogen receptor-positive breast cancer. Semin. Cancer Biol. 40-41, 170\u2013191. 10.1016/j.semcancer.2016.03.001", "ArticleIdList": ["10.1016/j.semcancer.2016.03.001", "PMC5033666", "27016037"]}, {"Citation": "Baldwin E. L., Osheroff N. (2005). Etoposide, topoisomerase II and cancer. Curr. Med. Chem. Anticancer Agents 5 (4), 363\u2013372. 10.2174/1568011054222364", "ArticleIdList": ["10.2174/1568011054222364", "16101488"]}, {"Citation": "Bazhabayi M., Qiu X., Li X., Yang A., Wen W., Zhang X., et al. (2021). CircGFRA1 facilitates the malignant progression of HER-2-positive breast cancer via acting as a sponge of miR-1228 and enhancing AIFM2 expression. J. Cell. Mol. Med. 25 (21), 10248\u201310256. 10.1111/jcmm.16963", "ArticleIdList": ["10.1111/jcmm.16963", "PMC8572792", "34668628"]}, {"Citation": "Beatty A., Singh T., Tyurina Y. Y., Tyurin V. A., Samovich S., Nicolas E., et al. (2021). Ferroptotic cell death triggered by conjugated linolenic acids is mediated by ACSL1. Nat. Commun. 12 (1), 2244. 10.1038/s41467-021-22471-y", "ArticleIdList": ["10.1038/s41467-021-22471-y", "PMC8046803", "33854057"]}, {"Citation": "Bersuker K., Hendricks J. M., Li Z., Magtanong L., Ford B., Tang P. H., et al. (2019). The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis. Nature 575 (7784), 688\u2013692. 10.1038/s41586-019-1705-2", "ArticleIdList": ["10.1038/s41586-019-1705-2", "PMC6883167", "31634900"]}, {"Citation": "Chu M.-L., Lin P.-W., Liu Y.-W., Wu S. Y., Lan S. H., Su C. L., et al. (2023). Formosanin C suppresses cancer cell proliferation and migration by impeding autophagy machinery. Kaohsiung J. Med. Sci. 39 (5), 489\u2013500. 10.1002/kjm2.12658", "ArticleIdList": ["10.1002/kjm2.12658", "36866653"]}, {"Citation": "Cao X., Li Y., Wang Y., Yu T., Zhu C., Zhang X., et al. (2022). Curcumin suppresses tumorigenesis by ferroptosis in breast cancer. PloS one 17 (1), e0261370. 10.1371/journal.pone.0261370", "ArticleIdList": ["10.1371/journal.pone.0261370", "PMC8765616", "35041678"]}, {"Citation": "Caracas HCPM, Maciel J. V. B., Martins PMRES, de Souza M. M. G., Maia L. C. (2009). The use of lidocaine as an anti-inflammatory substance: a systematic review. J. Dent. 37 (2), 93\u201397. 10.1016/j.jdent.2008.10.005", "ArticleIdList": ["10.1016/j.jdent.2008.10.005", "19058888"]}, {"Citation": "Chen G.-Q., Benthani F. A., Wu J., Liang D., Bian Z. X., Jiang X. (2020b). Artemisinin compounds sensitize cancer cells to ferroptosis by regulating iron homeostasis. Cell. death Differ. 27 (1), 242\u2013254. 10.1038/s41418-019-0352-3", "ArticleIdList": ["10.1038/s41418-019-0352-3", "PMC7205875", "31114026"]}, {"Citation": "Chen H. C., Tang H. H., Hsu W. H., Wu S. Y., Cheng W. H., Wang B. Y., et al. (2022b). Vulnerability of triple-negative breast cancer to saponin Formosanin C-induced ferroptosis. Antioxidants (Basel, Switz. 11 (2), 298. 10.3390/antiox11020298", "ArticleIdList": ["10.3390/antiox11020298", "PMC8868405", "35204181"]}, {"Citation": "Chen J., Qin C., Zhou Y., Chen Y., Mao M., Yang J. (2022c). Metformin may induce ferroptosis by inhibiting autophagy via lncRNA H19 in breast cancer. FEBS open bio 12 (1), 146\u2013153. 10.1002/2211-5463.13314", "ArticleIdList": ["10.1002/2211-5463.13314", "PMC8727937", "34644456"]}, {"Citation": "Chen P., Wu S., Dong X., Zhou M., Xu P., Chen B. (2022a). Formosanin C induces autophagy-mediated apoptosis in multiple myeloma cells through the PI3K/AKT/mTOR signaling pathway. Hematology 27 (1), 977\u2013986. 10.1080/16078454.2022.2117126", "ArticleIdList": ["10.1080/16078454.2022.2117126", "36053135"]}, {"Citation": "Chen X., Kang R., Kroemer G., Tang D. (2021). Broadening horizons: the role of ferroptosis in cancer. Nat. Rev. Clin. Oncol. 18 (5), 280\u2013296. 10.1038/s41571-020-00462-0", "ArticleIdList": ["10.1038/s41571-020-00462-0", "33514910"]}, {"Citation": "Chen X., Yu C., Kang R., Tang D. (2020a). Iron metabolism in ferroptosis. Front. Cell. Dev. Biol. 8, 590226. 10.3389/fcell.2020.590226", "ArticleIdList": ["10.3389/fcell.2020.590226", "PMC7575751", "33117818"]}, {"Citation": "Chen Y., Yao Z., Liu P., Hu Q., Huang Y., Ping L., et al. (2023). A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy. Acta biomater. 159, 275\u2013288. 10.1016/j.actbio.2023.01.050", "ArticleIdList": ["10.1016/j.actbio.2023.01.050", "36709836"]}, {"Citation": "Christensen R., Kristensen P. K., Bartels E. M., Bliddal H., Astrup A. (2007). Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet 370 (9600), 1706\u20131713. 10.1016/S0140-6736(07)61721-8", "ArticleIdList": ["10.1016/S0140-6736(07)61721-8", "18022033"]}, {"Citation": "Cory H., Passarelli S., Szeto J., Tamez M., Mattei J. (2018). The role of polyphenols in human health and food systems: a mini-review. Front. Nutr. 5, 87. 10.3389/fnut.2018.00087", "ArticleIdList": ["10.3389/fnut.2018.00087", "PMC6160559", "30298133"]}, {"Citation": "Cui P., Lin Q., Fang D., Zhang L., Li R., Cheng J., et al. (2018). Tung tree (vernicia fordii, hemsl.) genome and transcriptome sequencing reveals Co-ordinate up-regulation of fatty acid \u03b2-oxidation and triacylglycerol biosynthesis pathways during eleostearic acid accumulation in seeds. Plant Cell. Physiol. 59 (10), 1990\u20132003. 10.1093/pcp/pcy117", "ArticleIdList": ["10.1093/pcp/pcy117", "30137600"]}, {"Citation": "Dai X., Zhang X., Chen W., Chen Y., Zhang Q., Mo S., et al. (2021). Dihydroartemisinin: a potential natural anticancer drug. Int. J. Biol. Sci. 17 (2), 603\u2013622. 10.7150/ijbs.50364", "ArticleIdList": ["10.7150/ijbs.50364", "PMC7893584", "33613116"]}, {"Citation": "Ding Y., Chen X., Liu C., Ge W., Wang Q., Hao X., et al. (2021). Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. J. Hematol. Oncol. 14 (1), 19. 10.1186/s13045-020-01016-8", "ArticleIdList": ["10.1186/s13045-020-01016-8", "PMC7816340", "33472669"]}, {"Citation": "Dixon S. J., Lemberg K. M., Lamprecht M. R., Skouta R., Zaitsev E. M., Gleason C. E., et al. (2012). Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 149 (5), 1060\u20131072. 10.1016/j.cell.2012.03.042", "ArticleIdList": ["10.1016/j.cell.2012.03.042", "PMC3367386", "22632970"]}, {"Citation": "Dodo K., Minato T., Noguchi-Yachide T., Suganuma M., Hashimoto Y. (2008). Antiproliferative and apoptosis-inducing activities of alkyl gallate and gallamide derivatives related to (-)-epigallocatechin gallate. Bioorg Med. Chem. 16 (17), 7975\u20137982. 10.1016/j.bmc.2008.07.063", "ArticleIdList": ["10.1016/j.bmc.2008.07.063", "18693020"]}, {"Citation": "Doll S., Conrad M. (2017). Iron and ferroptosis: a still ill-defined liaison. IUBMB Life 69 (6), 423\u2013434. 10.1002/iub.1616", "ArticleIdList": ["10.1002/iub.1616", "28276141"]}, {"Citation": "Doll S., Freitas F. P., Shah R., Aldrovandi M., da Silva M. C., Ingold I., et al. (2019). FSP1 is a glutathione-independent ferroptosis suppressor. Nature 575 (7784), 693\u2013698. 10.1038/s41586-019-1707-0", "ArticleIdList": ["10.1038/s41586-019-1707-0", "31634899"]}, {"Citation": "Doll S., Proneth B., Tyurina Y. Y., Panzilius E., Kobayashi S., Ingold I., et al. (2017). ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nat. Chem. Biol. 13 (1), 91\u201398. 10.1038/nchembio.2239", "ArticleIdList": ["10.1038/nchembio.2239", "PMC5610546", "27842070"]}, {"Citation": "Dolma S., Lessnick S. L., Hahn W. C., Stockwell B. R. (2003). Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. Cancer Cell. 3 (3), 285\u2013296. 10.1016/s1535-6108(03)00050-3", "ArticleIdList": ["10.1016/s1535-6108(03)00050-3", "12676586"]}, {"Citation": "Dowdle W. E., Nyfeler B., Nagel J., Elling R. A., Liu S., Triantafellow E., et al. (2014). Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo . Nat. Cell. Biol. 16 (11), 1069\u20131079. 10.1038/ncb3053", "ArticleIdList": ["10.1038/ncb3053", "25327288"]}, {"Citation": "Du X., Zhang J., Liu L., Xu B., Han H., Dai W., et al. (2022). A novel anticancer property of Lycium barbarum polysaccharide in triggering ferroptosis of breast cancer cells. J. Zhejiang Univ. Sci. B 23 (4), 286\u2013299. 10.1631/jzus.B2100748", "ArticleIdList": ["10.1631/jzus.B2100748", "PMC9002246", "35403384"]}, {"Citation": "Duan W., Hu J., Liu Y. (2019). Ketamine inhibits colorectal cancer cells malignant potential via blockage of NMDA receptor. Exp. Mol. Pathol. 107, 171\u2013178. 10.1016/j.yexmp.2019.02.004", "ArticleIdList": ["10.1016/j.yexmp.2019.02.004", "30817910"]}, {"Citation": "Dundee J. W., Knox J. W., Black G. W., Moore J., Pandit S. K., Bovill J., et al. (1970). Ketamine as an induction agent in anaesthetics. Lancet 1 (7661), 1370\u20131371. 10.1016/s0140-6736(70)91273-0", "ArticleIdList": ["10.1016/s0140-6736(70)91273-0", "4194126"]}, {"Citation": "Elakkad Y. E., Mohamed S. N. S., Abuelezz N. Z. (2021). Potentiating the cytotoxic activity of a novel simvastatin-loaded cubosome against breast cancer cells: insights on dual cell death via ferroptosis and apoptosis. Breast cancer 13, 675\u2013689. 10.2147/bctt.S336712", "ArticleIdList": ["10.2147/bctt.S336712", "PMC8684378", "34934357"]}, {"Citation": "Feng Y., He D., Yao Z., Klionsky D. J. (2014). The machinery of macroautophagy. Cell. Res. 24 (1), 24\u201341. 10.1038/cr.2013.168", "ArticleIdList": ["10.1038/cr.2013.168", "PMC3879710", "24366339"]}, {"Citation": "Gao X., Lu Y., Fang L., Fang X., Xing Y., Gou S., et al. (2013). Synthesis and anticancer activity of some novel 2-phenazinamine derivatives. Eur. J. Med. Chem. 69, 1\u20139. 10.1016/j.ejmech.2013.07.017", "ArticleIdList": ["10.1016/j.ejmech.2013.07.017", "23995213"]}, {"Citation": "Geyer C. E., Forster J., Lindquist D., Chan S., Romieu C. G., Pienkowski T., et al. (2006). Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N. Engl. J. Med. 355 (26), 2733\u20132743. 10.1056/NEJMoa064320", "ArticleIdList": ["10.1056/NEJMoa064320", "17192538"]}, {"Citation": "Gomme P. T., McCann K. B., Bertolini J. (2005). Transferrin: structure, function and potential therapeutic actions. Drug Discov. Today 10 (4), 267\u2013273. 10.1016/S1359-6446(04)03333-1", "ArticleIdList": ["10.1016/S1359-6446(04)03333-1", "15708745"]}, {"Citation": "Gradishar W. J., Moran M. S., Abraham J., Aft R., Agnese D., Allison K. H., et al. (2022). Breast cancer, version 3.2022, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc Netw. 20 (6), 691\u2013722. 10.6004/jnccn.2022.0030", "ArticleIdList": ["10.6004/jnccn.2022.0030", "35714673"]}, {"Citation": "Haque A., Brazeau D., Amin A. R. (2021). Perspectives on natural compounds in chemoprevention and treatment of cancer: an update with new promising compounds. Eur. J. Cancer 149, 165\u2013183. 10.1016/j.ejca.2021.03.009", "ArticleIdList": ["10.1016/j.ejca.2021.03.009", "PMC8113151", "33865202"]}, {"Citation": "Hargreaves I., Heaton R. A., Mantle D. (2020). Disorders of human coenzyme Q10 metabolism: an overview. Int. J. Mol. Sci. 21 (18), 6695. 10.3390/ijms21186695", "ArticleIdList": ["10.3390/ijms21186695", "PMC7555759", "32933108"]}, {"Citation": "He G.-N., Bao N.-R., Wang S., Xi M., Zhang T. H., Chen F. S. (2021). Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1/miR-214-3p/GPX4. Drug Des. Dev. Ther. 15, 3965\u20133978. 10.2147/DDDT.S332847", "ArticleIdList": ["10.2147/DDDT.S332847", "PMC8458041", "34566408"]}, {"Citation": "Heading C. Siramesine H Lundbeck (2001). Siramesine H Lundbeck. Curr. Opin. Investig. Drugs 2 (2), 266\u2013270.", "ArticleIdList": ["11816842"]}, {"Citation": "Heckman-Stoddard B. M., DeCensi A., Sahasrabuddhe V. V., Ford L. G. (2017). Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia 60 (9), 1639\u20131647. 10.1007/s00125-017-4372-6", "ArticleIdList": ["10.1007/s00125-017-4372-6", "PMC5709147", "28776080"]}, {"Citation": "Hishikawa D., Shindou H., Kobayashi S., Nakanishi H., Taguchi R., Shimizu T. (2008). Discovery of a lysophospholipid acyltransferase family essential for membrane asymmetry and diversity. Proc. Natl. Acad. Sci. U. S. A. 105 (8), 2830\u20132835. 10.1073/pnas.0712245105", "ArticleIdList": ["10.1073/pnas.0712245105", "PMC2268545", "18287005"]}, {"Citation": "Hou W., Xie Y., Song X., Sun X., Lotze M. T., Zeh H. J., et al. (2016). Autophagy promotes ferroptosis by degradation of ferritin. Autophagy 12 (8), 1425\u20131428. 10.1080/15548627.2016.1187366", "ArticleIdList": ["10.1080/15548627.2016.1187366", "PMC4968231", "27245739"]}, {"Citation": "Hou Y., Cai S., Yu S., Lin H. (2021). Metformin induces ferroptosis by targeting miR-324-3p/GPX4 axis in breast cancer. Acta biochimica biophysica Sinica 53 (3), 333\u2013341. 10.1093/abbs/gmaa180", "ArticleIdList": ["10.1093/abbs/gmaa180", "33522578"]}, {"Citation": "Huang P., Zhao H., Pan X., Li J., Pan W., Dai H., et al. (2023). SIRT3-mediated autophagy contributes to ferroptosis-induced anticancer by inducing the formation of BECN1-SLC7A11 complex. Biochem. Pharmacol. 213, 115592. 10.1016/j.bcp.2023.115592", "ArticleIdList": ["10.1016/j.bcp.2023.115592", "37196680"]}, {"Citation": "Huang Y., Dai Z., Barbacioru C., Sad\u00e9e W. (2005). Cystine-glutamate transporter SLC7A11 in cancer chemosensitivity and chemoresistance. Cancer Res. 65 (16), 7446\u20137454. 10.1158/0008-5472.CAN-04-4267", "ArticleIdList": ["10.1158/0008-5472.CAN-04-4267", "16103098"]}, {"Citation": "Hussain H., Ali I., Wang D., Hakkim F. L., Westermann B., Ahmed I., et al. (2021). Glycyrrhetinic acid: a promising scaffold for the discovery of anticancer agents. Expert Opin. Drug Discov. 16 (12), 1497\u20131516. 10.1080/17460441.2021.1956901", "ArticleIdList": ["10.1080/17460441.2021.1956901", "34294017"]}, {"Citation": "Jing S., Lu Y., Zhang J., Ren Y., Mo Y., Liu D., et al. (2022). Levistilide a induces ferroptosis by activating the Nrf2/HO-1 signaling pathway in breast cancer cells. Drug Des. Dev. Ther. 16, 2981\u20132993. 10.2147/dddt.S374328", "ArticleIdList": ["10.2147/dddt.S374328", "PMC9464640", "36105321"]}, {"Citation": "Kapinova A., Kubatka P., Golubnitschaja O., Kello M., Zubor P., Solar P., et al. (2018). Dietary phytochemicals in breast cancer research: anticancer effects and potential utility for effective chemoprevention. Environ. Health Prev. Med. 23 (1), 36. 10.1186/s12199-018-0724-1", "ArticleIdList": ["10.1186/s12199-018-0724-1", "PMC6085646", "30092754"]}, {"Citation": "Kato I., Kasukabe T., Kumakura S. (2020). Menin-MLL inhibitors induce ferroptosis and enhance the anti-proliferative activity of auranofin in several types of cancer cells. Int. J. Oncol. 57 (4), 1057\u20131071. 10.3892/ijo.2020.5116", "ArticleIdList": ["10.3892/ijo.2020.5116", "32945449"]}, {"Citation": "Khorsandi K., Kianmehr Z., Hosseinmardi Z., Hosseinzadeh R. (2020). Anti-cancer effect of gallic acid in presence of low level laser irradiation: ROS production and induction of apoptosis and ferroptosis. Cancer Cell. Int. 20, 18. 10.1186/s12935-020-1100-y", "ArticleIdList": ["10.1186/s12935-020-1100-y", "PMC6958578", "31956296"]}, {"Citation": "Kourie H. R., El Rassy E., Clatot F., de Azambuja E., Lambertini M. (2017). Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib. Onco Targets Ther. 10, 3363\u20133372. 10.2147/OTT.S122397", "ArticleIdList": ["10.2147/OTT.S122397", "PMC5513878", "28744140"]}, {"Citation": "Krishnaiah M., de Almeida N. R., Udumula V., Song Z., Chhonker Y. S., Abdelmoaty M. M., et al. (2018). Synthesis, biological evaluation, and metabolic stability of phenazine derivatives as antibacterial agents. Eur. J. Med. Chem. 143, 936\u2013947. 10.1016/j.ejmech.2017.11.026", "ArticleIdList": ["10.1016/j.ejmech.2017.11.026", "29227933"]}, {"Citation": "K\u00fcch E.-M., Vellaramkalayil R., Zhang I., Lehnen D., Br\u00fcgger B., Sreemmel W., et al. (2014). Differentially localized acyl-CoA synthetase 4 isoenzymes mediate the metabolic channeling of fatty acids towards phosphatidylinositol. Biochim. Biophys. Acta 1841 (2), 227\u2013239. 10.1016/j.bbalip.2013.10.018", "ArticleIdList": ["10.1016/j.bbalip.2013.10.018", "24201376"]}, {"Citation": "K\u00fchn L. C. (2015). Iron regulatory proteins and their role in controlling iron metabolism. Metallomics 7 (2), 232\u2013243. 10.1039/c4mt00164h", "ArticleIdList": ["10.1039/c4mt00164h", "25306858"]}, {"Citation": "Lee J.-Y., Kim W. K., Bae K.-H., Lee S. C., Lee E. W. (2021b). Lipid metabolism and ferroptosis. Biology 10 (3), 184. 10.3390/biology10030184", "ArticleIdList": ["10.3390/biology10030184", "PMC8000263", "33801564"]}, {"Citation": "Lee N., Carlisle A. E., Peppers A., Park S. J., Doshi M. B., Spears M. E., et al. (2021c). xCT-driven expression of GPX4 determines sensitivity of breast cancer cells to ferroptosis inducers. Antioxidants (Basel, Switz. 10 (2), 317. 10.3390/antiox10020317", "ArticleIdList": ["10.3390/antiox10020317", "PMC7923775", "33672555"]}, {"Citation": "Lee N., Carlisle A. E., Peppers A., Park S. J., Doshi M. B., Spears M. E., et al. (2021a). xCT-driven expression of GPX4 determines sensitivity of breast cancer cells to ferroptosis inducers. Antioxidants (Basel, Switz. 10 (2), 317. 10.3390/antiox10020317", "ArticleIdList": ["10.3390/antiox10020317", "PMC7923775", "33672555"]}, {"Citation": "Li H., Liu W., Zhang X., Wu F., Sun D., Wang Z. (2021). Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis. Biochem. biophysical Res. Commun. 585, 111\u2013116. 10.1016/j.bbrc.2021.11.029", "ArticleIdList": ["10.1016/j.bbrc.2021.11.029", "34800882"]}, {"Citation": "Li P., Lin Q., Sun S., Yang N., Xia Y., Cao S., et al. (2022). Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism. Cell. death Dis. 13 (9), 808. 10.1038/s41419-022-05242-5", "ArticleIdList": ["10.1038/s41419-022-05242-5", "PMC9492666", "36130940"]}, {"Citation": "Li R., Zhang J., Zhou Y., Gao Q., Wang R., Fu Y., et al. (2020). Transcriptome investigation and in vitro verification of curcumin-induced HO-1 as a feature of ferroptosis in breast cancer cells. Oxidative Med. Cell. Longev. 2020, 3469840. 10.1155/2020/3469840", "ArticleIdList": ["10.1155/2020/3469840", "PMC7691002", "33294119"]}, {"Citation": "Li T., Chen L., Zhao H., Wu L., Masters J., Han C., et al. (2019). Both Bupivacaine and Levobupivacaine inhibit colon cancer cell growth but not melanoma cells in vitro . J. Anesth. 33 (1), 17\u201325. 10.1007/s00540-018-2577-6", "ArticleIdList": ["10.1007/s00540-018-2577-6", "PMC6373235", "30426213"]}, {"Citation": "Lin Y. S., Shen Y. C., Wu C. Y., Tsai Y. Y., Yang Y. H., Lin Y. Y., et al. (2019). Danshen improves survival of patients with breast cancer and Dihydroisotanshinone I induces ferroptosis and apoptosis of breast cancer cells. Front. Pharmacol. 10, 1226. 10.3389/fphar.2019.01226", "ArticleIdList": ["10.3389/fphar.2019.01226", "PMC6836808", "31736748"]}, {"Citation": "Liu J., Kuang F., Kroemer G., Klionsky D. J., Kang R., Tang D. (2020). Autophagy-dependent ferroptosis: machinery and regulation. Cell. Chem. Biol. 27 (4), 420\u2013435. 10.1016/j.chembiol.2020.02.005", "ArticleIdList": ["10.1016/j.chembiol.2020.02.005", "PMC7166192", "32160513"]}, {"Citation": "Liu S.-J., Zhao Q., Peng C., Mao Q., Wu F., Zhang F. H., et al. (2021). Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit breast adenocarcinoma cell proliferation. Eur. J. Med. Chem. 217, 113359. 10.1016/j.ejmech.2021.113359", "ArticleIdList": ["10.1016/j.ejmech.2021.113359", "33725632"]}, {"Citation": "Ma S., Henson E. S., Chen Y., Gibson S. B. (2016). Ferroptosis is induced following siramesine and lapatinib treatment of breast cancer cells. Cell. death Dis. 7 (7), e2307. 10.1038/cddis.2016.208", "ArticleIdList": ["10.1038/cddis.2016.208", "PMC4973350", "27441659"]}, {"Citation": "Mai T. T., Hama\u00ef A., Hienzsch A., Ca\u00f1eque T., M\u00fcller S., Wicinski J., et al. (2017). Salinomycin kills cancer stem cells by sequestering iron in lysosomes. Nat. Chem. 9 (10), 1025\u20131033. 10.1038/nchem.2778", "ArticleIdList": ["10.1038/nchem.2778", "PMC5890907", "28937680"]}, {"Citation": "Man S., Gao W., Zhang Y., Liu Z., Yan L., Huang L., et al. (2011). Formosanin C-inhibited pulmonary metastasis through repression of matrix metalloproteinases on mouse lung adenocarcinoma. Cancer Biol. Ther. 11 (6), 592\u2013598. 10.4161/cbt.11.6.14668", "ArticleIdList": ["10.4161/cbt.11.6.14668", "21304274"]}, {"Citation": "Mancias J. D., Wang X., Gygi S. P., Harper J. W., Kimmelman A. C. (2014). Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature 509 (7498), 105\u2013109. 10.1038/nature13148", "ArticleIdList": ["10.1038/nature13148", "PMC4180099", "24695223"]}, {"Citation": "Mao C., Wang X., Liu Y., Wang M., Yan B., Jiang Y., et al. (2018). A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Res. 78 (13), 3484\u20133496. 10.1158/0008-5472.CAN-17-3454", "ArticleIdList": ["10.1158/0008-5472.CAN-17-3454", "PMC8073197", "29588351"]}, {"Citation": "Meresse P., Dechaux E., Monneret C., Bertounesque E. (2004). Etoposide: discovery and medicinal chemistry. Curr. Med. Chem. 11 (18), 2443\u20132466. 10.2174/0929867043364531", "ArticleIdList": ["10.2174/0929867043364531", "15379707"]}, {"Citation": "Muckenthaler M. U., Galy B., Hentze M. W. (2008). Systemic iron homeostasis and the iron-responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annu. Rev. Nutr. 28, 197\u2013213. 10.1146/annurev.nutr.28.061807.155521", "ArticleIdList": ["10.1146/annurev.nutr.28.061807.155521", "18489257"]}, {"Citation": "Nagpal A., Redvers R. P., Ling X., Ayton S., Fuentes M., Tavancheh E., et al. (2019). Neoadjuvant neratinib promotes ferroptosis and inhibits brain metastasis in a novel syngeneic model of spontaneous HER2(+ve) breast cancer metastasis. Breast cancer Res. BCR 21 (1), 94. 10.1186/s13058-019-1177-1", "ArticleIdList": ["10.1186/s13058-019-1177-1", "PMC6693253", "31409375"]}, {"Citation": "Ning D., Yang X., Wang T., Jiang Q., Yu J., Wang D. (2021). Atorvastatin treatment ameliorates cardiac function and remodeling induced by isoproterenol attack through mitigation of ferroptosis. Biochem. biophysical Res. Commun. 574, 39\u201347. 10.1016/j.bbrc.2021.08.017", "ArticleIdList": ["10.1016/j.bbrc.2021.08.017", "34438345"]}, {"Citation": "Niu B., Liao K., Zhou Y., Wen T., Quan G., Pan X., et al. (2021). Application of glutathione depletion in cancer therapy: enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials 277, 121110. 10.1016/j.biomaterials.2021.121110", "ArticleIdList": ["10.1016/j.biomaterials.2021.121110", "34482088"]}, {"Citation": "Ozkan E., Bakar-Ates F. (2023a). Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells. Life Sci. 312, 121222. 10.1016/j.lfs.2022.121222", "ArticleIdList": ["10.1016/j.lfs.2022.121222", "36442526"]}, {"Citation": "Ozkan E., Bakar-Ates F. (2023b). Etoposide in combination with erastin synergistically altered iron homeostasis and induced ferroptotic cell death through regulating IREB2/FPN1 expression in estrogen receptor positive-breast cancer cells. Life Sci. 312, 121222. 10.1016/j.lfs.2022.121222", "ArticleIdList": ["10.1016/j.lfs.2022.121222", "36442526"]}, {"Citation": "Pernicova I., Korbonits M. (2014). Metformin--mode of action and clinical implications for diabetes and cancer. Nat. Rev. Endocrinol. 10 (3), 143\u2013156. 10.1038/nrendo.2013.256", "ArticleIdList": ["10.1038/nrendo.2013.256", "24393785"]}, {"Citation": "Rabindran S. K., Discafani C. M., Rosfjord E. C., Baxter M., Floyd M. B., Golas J., et al. (2004). Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase. Cancer Res. 64 (11), 3958\u20133965. 10.1158/0008-5472.CAN-03-2868", "ArticleIdList": ["10.1158/0008-5472.CAN-03-2868", "15173008"]}, {"Citation": "Rizzollo F., More S., Vangheluwe P., Agostinis P. (2021). The lysosome as a master regulator of iron metabolism. Trends Biochem. Sci. 46 (12), 960\u2013975. 10.1016/j.tibs.2021.07.003", "ArticleIdList": ["10.1016/j.tibs.2021.07.003", "34384657"]}, {"Citation": "R\u00f6hrig F., Schulze A. (2016). The multifaceted roles of fatty acid synthesis in cancer. Nat. Rev. Cancer 16 (11), 732\u2013749. 10.1038/nrc.2016.89", "ArticleIdList": ["10.1038/nrc.2016.89", "27658529"]}, {"Citation": "Roohbakhsh A., Iranshahy M., Iranshahi M. (2016). Glycyrrhetinic acid and its derivatives: anti-cancer and cancer chemopreventive properties, mechanisms of action and structure- cytotoxic activity relationship. Curr. Med. Chem. 23 (5), 498\u2013517. 10.2174/0929867323666160112122256", "ArticleIdList": ["10.2174/0929867323666160112122256", "26758798"]}, {"Citation": "Sato H., Tamba M., Ishii T., Bannai S. (1999). Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274 (17), 11455\u201311458. 10.1074/jbc.274.17.11455", "ArticleIdList": ["10.1074/jbc.274.17.11455", "10206947"]}, {"Citation": "Shi J., Vakoc C. R. (2014). The mechanisms behind the therapeutic activity of BET bromodomain inhibition. Mol. Cell. 54 (5), 728\u2013736. 10.1016/j.molcel.2014.05.016", "ArticleIdList": ["10.1016/j.molcel.2014.05.016", "PMC4236231", "24905006"]}, {"Citation": "Smith-Apeldoorn S. Y., Veraart J. K., Spijker J., Kamphuis J., Schoevers R. A. (2022). Maintenance ketamine treatment for depression: a systematic review of efficacy, safety, and tolerability. Lancet Psychiatry 9 (11), 907\u2013921. 10.1016/S2215-0366(22)00317-0", "ArticleIdList": ["10.1016/S2215-0366(22)00317-0", "36244360"]}, {"Citation": "Sopik V., Nofech-Mozes S., Sun P., Narod S. A. (2016). The relationship between local recurrence and death in early-stage breast cancer. Breast Cancer Res. Treat. 155 (1), 175\u2013185. 10.1007/s10549-015-3666-y", "ArticleIdList": ["10.1007/s10549-015-3666-y", "26712515"]}, {"Citation": "Su Y., Zhao B., Zhou L., Zhang Z., Shen Y., Lv H., et al. (2020). Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs. Cancer Lett. 483, 127\u2013136. 10.1016/j.canlet.2020.02.015", "ArticleIdList": ["10.1016/j.canlet.2020.02.015", "32067993"]}, {"Citation": "Sui S., Xu S., Pang D. (2022). Emerging role of ferroptosis in breast cancer: new dawn for overcoming tumor progression. Pharmacol. Ther. 232, 107992. 10.1016/j.pharmthera.2021.107992", "ArticleIdList": ["10.1016/j.pharmthera.2021.107992", "34606782"]}, {"Citation": "Sui S., Zhang J., Xu S., Wang Q., Wang P., Pang D. (2019). Ferritinophagy is required for the induction of ferroptosis by the bromodomain protein BRD4 inhibitor (+)-JQ1 in cancer cells. Cell. death Dis. 10 (5), 331. 10.1038/s41419-019-1564-7", "ArticleIdList": ["10.1038/s41419-019-1564-7", "PMC6465411", "30988278"]}, {"Citation": "Sun C., Liu P., Pei L., Zhao M., Huang Y. (2022). Propofol inhibits proliferation and augments the anti-tumor effect of doxorubicin and paclitaxel partly through promoting ferroptosis in triple-negative breast cancer cells. Front. Oncol. 12, 837974. 10.3389/fonc.2022.837974", "ArticleIdList": ["10.3389/fonc.2022.837974", "PMC8996258", "35419287"]}, {"Citation": "Sun D., Li Y. C., Zhang X. Y. (2021a). Lidocaine promoted ferroptosis by targeting miR-382-5p/SLC7A11 Axis in ovarian and breast cancer. Front. Pharmacol. 12, 681223. 10.3389/fphar.2021.681223", "ArticleIdList": ["10.3389/fphar.2021.681223", "PMC8188239", "34122108"]}, {"Citation": "Sun L. L., Linghu D. L., Hung M. C. (2021b). Ferroptosis: a promising target for cancer immunotherapy. Am. J. cancer Res. 11 (12), 5856\u20135863.", "ArticleIdList": ["PMC8727800", "35018229"]}, {"Citation": "Sung H., Ferlay J., Siegel R. L., Laversanne M., Soerjomataram I., Jemal A., et al. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71 (3), 209\u2013249. 10.3322/caac.21660", "ArticleIdList": ["10.3322/caac.21660", "33538338"]}, {"Citation": "Tang D., Kroemer G. (2020). Ferroptosis. Curr. Biol. CB 30 (21), R1292-R1297\u2013R97. 10.1016/j.cub.2020.09.068", "ArticleIdList": ["10.1016/j.cub.2020.09.068", "33142092"]}, {"Citation": "Tian F., Woo S. Y., Lee S. Y., Park S. B., Zheng Y., Chun H. S. (2022). Antifungal activity of essential oil and plant-derived natural compounds against Aspergillus flavus. Antibiot. (Basel) 11 (12), 1727. 10.3390/antibiotics11121727", "ArticleIdList": ["10.3390/antibiotics11121727", "PMC9774910", "36551384"]}, {"Citation": "Tolaney S. (2014). New HER2-positive targeting agents in clinical practice. Curr. Oncol. Rep. 16 (1), 359. 10.1007/s11912-013-0359-8", "ArticleIdList": ["10.1007/s11912-013-0359-8", "24442625"]}, {"Citation": "Wang J., Li Y., Zhang J., Luo C. (2023). Isoliquiritin modulates ferroptosis via NF-\u03baB signaling inhibition and alleviates doxorubicin resistance in breast cancer. Immunopharmacol. Immunotoxicol. 2023, 443\u2013454. 10.1080/08923973.2023.2165943", "ArticleIdList": ["10.1080/08923973.2023.2165943", "36605015"]}, {"Citation": "Wang L., Chen Y., Mi Y., Qiao J., Jin H., Li J., et al. (2021). ATF2 inhibits ani-tumor effects of BET inhibitor in a negative feedback manner by attenuating ferroptosis. Biochem. biophysical Res. Commun. 558, 216\u2013223. 10.1016/j.bbrc.2020.08.113", "ArticleIdList": ["10.1016/j.bbrc.2020.08.113", "33008584"]}, {"Citation": "Wang W., Green M., Choi J. E., Gij\u00f3n M., Kennedy P. D., Johnson J. K., et al. (2019). CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569 (7755), 270\u2013274. 10.1038/s41586-019-1170-y", "ArticleIdList": ["10.1038/s41586-019-1170-y", "PMC6533917", "31043744"]}, {"Citation": "Wei Y., Zhu Z., Hu H., Guan J., Yang B., Zhao H. (2022). Eupaformosanin induces apoptosis and ferroptosis through ubiquitination of mutant p53 in triple-negative breast cancer. Eur. J. Pharmacol. 924, 174970. 10.1016/j.ejphar.2022.174970", "ArticleIdList": ["10.1016/j.ejphar.2022.174970", "35469839"]}, {"Citation": "Wen W., Jin K., Che Y., Du L.-Y., Wang L.-N. (2021b). \u201cArnicolide D inhibits oxidative stress-induced breast cancer cell growth and invasion through apoptosis,\u201d in Ferroptosis, and Parthanatos. Anti-cancer agents in medicinal chemistry 202210. 2174/1871520623666221208102021.", "ArticleIdList": ["36503456"]}, {"Citation": "Wen Y., Chen H., Zhang L., Wu M., Zhang F., Yang D., et al. (2021a). Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells. Free Radic. Biol. Med. 173, 41\u201351. 10.1016/j.freeradbiomed.2021.07.019", "ArticleIdList": ["10.1016/j.freeradbiomed.2021.07.019", "34271106"]}, {"Citation": "Williamson G. (2017). The role of polyphenols in modern nutrition. Nutr. Bull. 42 (3), 226\u2013235. 10.1111/nbu.12278", "ArticleIdList": ["10.1111/nbu.12278", "PMC5601283", "28983192"]}, {"Citation": "Wood E. R., Truesdale A. T., McDonald O. B., Yuan D., Hassell A., Dickerson S. H., et al. (2004). A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells. Cancer Res. 64 (18), 6652\u20136659. 10.1158/0008-5472.CAN-04-1168", "ArticleIdList": ["10.1158/0008-5472.CAN-04-1168", "15374980"]}, {"Citation": "Wu X., Li Y., Zhang S., Zhou X. (2021). Ferroptosis as a novel therapeutic target for cardiovascular disease. Theranostics 11 (7), 3052\u20133059. 10.7150/thno.54113", "ArticleIdList": ["10.7150/thno.54113", "PMC7847684", "33537073"]}, {"Citation": "Xie Y., Wang B., Zhao Y., Tao Z., Wang Y., Chen G., et al. (2022a). Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis. J. Hematol. Oncol. 15 (1), 72. 10.1186/s13045-022-01297-1", "ArticleIdList": ["10.1186/s13045-022-01297-1", "PMC9164506", "35659320"]}, {"Citation": "Xie Y., Zhou X., Li J., Yao X. C., Liu W. L., Kang F. H., et al. (2021). Identification of a new natural biflavonoids against breast cancer cells induced ferroptosis via the mitochondrial pathway. Bioorg. Chem. 109, 104744. 10.1016/j.bioorg.2021.104744", "ArticleIdList": ["10.1016/j.bioorg.2021.104744", "33639365"]}, {"Citation": "Xie Y., Zhou X., Li J., Yao X. C., Liu W. L., Xu P. S., et al. (2022b). Cytotoxic effects of the biflavonoids isolated from Selaginella trichoclada on MCF-7 cells and its potential mechanism. Bioorg. Med. Chem. Lett. 56, 128486. 10.1016/j.bmcl.2021.128486", "ArticleIdList": ["10.1016/j.bmcl.2021.128486", "34875389"]}, {"Citation": "Xiong H., Wang C., Wang Z., Jiang Z., Zhou J., Yao J. (2019). Intracellular cascade activated nanosystem for improving ER+ breast cancer therapy through attacking GSH-mediated metabolic vulnerability. J. Control. release official J. Control. Release Soc. 309, 145\u2013157. 10.1016/j.jconrel.2019.07.029", "ArticleIdList": ["10.1016/j.jconrel.2019.07.029", "31348976"]}, {"Citation": "Yan H., Bu P. (2021). Non-coding RNA in cancer. Essays Biochem. 65 (4), 625\u2013639. 10.1042/EBC20200032", "ArticleIdList": ["10.1042/EBC20200032", "PMC8564738", "33860799"]}, {"Citation": "Yan J., Liu W., Cai J., Wang Y., Li D., Hua H., et al. (2021). Advances in phenazines over the past decade: review of their pharmacological activities, mechanisms of action, biosynthetic pathways and synthetic strategies. Mar. Drugs 19 (11), 610. 10.3390/md19110610", "ArticleIdList": ["10.3390/md19110610", "PMC8620606", "34822481"]}, {"Citation": "Yang F., Xiao Y., Ding J.-H., Jin X., Ma D., Li D. Q., et al. (2023a). Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell. metab. 35 (1), 84\u2013100.e8. 10.1016/j.cmet.2022.09.021", "ArticleIdList": ["10.1016/j.cmet.2022.09.021", "36257316"]}, {"Citation": "Yang F., Xiao Y., Ding J. H., Jin X., Ma D., Li D. Q., et al. (2023b). Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell. metab. 35 (1), 84\u2013100.e8. 10.1016/j.cmet.2022.09.021", "ArticleIdList": ["10.1016/j.cmet.2022.09.021", "36257316"]}, {"Citation": "Yang H., Dou Q. P. (2010). Targeting apoptosis pathway with natural terpenoids: implications for treatment of breast and prostate cancer. Curr. Drug Targets 11 (6), 733\u2013744. 10.2174/138945010791170842", "ArticleIdList": ["10.2174/138945010791170842", "PMC3306610", "20298150"]}, {"Citation": "Yang J., Jia Z., Zhang J., Pan X., Wei Y., Ma S., et al. (2022a). Metabolic intervention nanoparticles for triple-negative breast cancer therapy via overcoming FSP1-mediated ferroptosis resistance. Adv. Healthc. Mater. 11 (13), e2102799. 10.1002/adhm.202102799", "ArticleIdList": ["10.1002/adhm.202102799", "35395704"]}, {"Citation": "Yang J., Zhou Y., Xie S., Wang J., Li Z., Chen L., et al. (2021). Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer. J. Exp. Clin. cancer Res. CR 40 (1), 206. 10.1186/s13046-021-02012-7", "ArticleIdList": ["10.1186/s13046-021-02012-7", "PMC8223374", "34162423"]}, {"Citation": "Yang W. S., SriRamaratnam R., Welsch M. E., Shimada K., Skouta R., Viswanathan V. S., et al. (2014). Regulation of ferroptotic cancer cell death by GPX4. Cell. 156 (1-2), 317\u2013331. 10.1016/j.cell.2013.12.010", "ArticleIdList": ["10.1016/j.cell.2013.12.010", "PMC4076414", "24439385"]}, {"Citation": "Yang Y., Lu Y., Zhang C., Guo Q., Zhang W., Wang T., et al. (2022b). Phenazine derivatives attenuate the stemness of breast cancer cells through triggering ferroptosis. Cell. Mol. life Sci. CMLS 79 (7), 360. 10.1007/s00018-022-04384-1", "ArticleIdList": ["10.1007/s00018-022-04384-1", "35690642"]}, {"Citation": "Yao M.-Y., Liu T., Zhang L., Wang M. J., Yang Y., Gao J. (2021a). Role of ferroptosis in neurological diseases. Neurosci. Lett. 747, 135614. 10.1016/j.neulet.2020.135614", "ArticleIdList": ["10.1016/j.neulet.2020.135614", "33485988"]}, {"Citation": "Yao X., Xie R., Cao Y., Tang J., Men Y., Peng H., et al. (2021b). Simvastatin induced ferroptosis for triple-negative breast cancer therapy. J. nanobiotechnology 19 (1), 311. 10.1186/s12951-021-01058-1", "ArticleIdList": ["10.1186/s12951-021-01058-1", "PMC8502296", "34627266"]}, {"Citation": "Yap A., Lopez-Olivo M. A., Dubowitz J., Hiller J., Riedel B. Global Onco-Anesthesia Research Collaboration Group (2019). Anesthetic technique and cancer outcomes: a meta-analysis of total intravenous versus volatile anesthesia. Can. J. Anaesth. 66 (5), 546\u2013561. 10.1007/s12630-019-01330-x", "ArticleIdList": ["10.1007/s12630-019-01330-x", "30834506"]}, {"Citation": "Ye F., Wu J., Zhang F. (2023). METTL16 epigenetically enhances GPX4 expression via m6A modification to promote breast cancer progression by inhibiting ferroptosis. Biochem. biophysical Res. Commun. 638, 1\u20136. 10.1016/j.bbrc.2022.10.065", "ArticleIdList": ["10.1016/j.bbrc.2022.10.065", "36434904"]}, {"Citation": "Ye Z., Liu W., Zhuo Q., Hu Q., Liu M., Sun Q., et al. (2020). Ferroptosis: final destination for cancer? Cell. Prolif. 53 (3), e12761. 10.1111/cpr.12761", "ArticleIdList": ["10.1111/cpr.12761", "PMC7106955", "32100402"]}, {"Citation": "Yin J., Lin Y., Fang W., Zhang X., Wei J., Hu G., et al. (2022). Tetrandrine citrate suppresses breast cancer via depletion of glutathione peroxidase 4 and activation of nuclear receptor coactivator 4-mediated ferritinophagy. Front. Pharmacol. 13, 820593. 10.3389/fphar.2022.820593", "ArticleIdList": ["10.3389/fphar.2022.820593", "PMC9124810", "35614944"]}, {"Citation": "Yu H., Guo P., Xie X., Wang Y., Chen G. (2017). Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J. Cell. Mol. Med. 21 (4), 648\u2013657. 10.1111/jcmm.13008", "ArticleIdList": ["10.1111/jcmm.13008", "PMC5345622", "27860262"]}, {"Citation": "Yu H., Yang C., Jian L., Guo S., Chen R., Li K., et al. (2019). Sulfasalazine-induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor. Oncol. Rep. 42 (2), 826\u2013838. 10.3892/or.2019.7189", "ArticleIdList": ["10.3892/or.2019.7189", "31173262"]}, {"Citation": "Zhai F. G., Liang Q. C., Wu Y. Y., Liu J. Q., Liu J. W. (2022). Red ginseng polysaccharide exhibits anticancer activity through GPX4 downregulation-induced ferroptosis. Pharm. Biol. 60 (1), 909\u2013914. 10.1080/13880209.2022.2066139", "ArticleIdList": ["10.1080/13880209.2022.2066139", "PMC9116236", "35575436"]}, {"Citation": "Zhang C., Liu X., Jin S., Chen Y., Guo R. (2022a). Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol. Cancer 21 (1), 47. 10.1186/s12943-022-01530-y", "ArticleIdList": ["10.1186/s12943-022-01530-y", "PMC8840702", "35151318"]}, {"Citation": "Zhang C., Xu L., Li X., Chen Y., Shi T., Wang Q. (2023). LINC00460 facilitates cell proliferation and inhibits ferroptosis in breast cancer through the miR-320a/MAL2 Axis. Technol. cancer Res. Treat. 22, 15330338231164359. 10.1177/15330338231164359", "ArticleIdList": ["10.1177/15330338231164359", "PMC10028644", "36938678"]}, {"Citation": "Zhang H., Ge Z., Wang Z., Gao Y., Wang Y., Qu X. (2021a). Circular RNA RHOT1 promotes progression and inhibits ferroptosis via mir-106a-5p/STAT3 axis in breast cancer. Aging 13 (6), 8115\u20138126. 10.18632/aging.202608", "ArticleIdList": ["10.18632/aging.202608", "PMC8034942", "33686957"]}, {"Citation": "Zhang J., Gao R. F., Li J., Yu K. d., Bi K. X. (2022b). Alloimperatorin activates apoptosis, ferroptosis, and oxeiptosis to inhibit the growth and invasion of breast cancer cells in vitro . Biochem. Cell. Biol. = Biochimie Biol. Cell. 100 (3), 213\u2013222. 10.1139/bcb-2021-0399", "ArticleIdList": ["10.1139/bcb-2021-0399", "35263194"]}, {"Citation": "Zhang Q., Qu H., Chen Y., Luo X., Chen C., Xiao B., et al. (2022c). Atorvastatin induces mitochondria-dependent ferroptosis via the modulation of nrf2-xCT/GPx4 Axis. Front. Cell. Dev. Biol. 10, 806081. 10.3389/fcell.2022.806081", "ArticleIdList": ["10.3389/fcell.2022.806081", "PMC8927716", "35309902"]}, {"Citation": "Zhang S., Hu R., Geng Y., Chen K., Wang L., Imam M. U. (2021b). The regulatory effects and the signaling pathways of natural bioactive compounds on ferroptosis. Foods 10 (12), 2952. 10.3390/foods10122952", "ArticleIdList": ["10.3390/foods10122952", "PMC8700948", "34945503"]}, {"Citation": "Zhao D., Long X.-D., Lu T.-F., Wang T., Zhang W. W., Liu Y. X., et al. (2015). Metformin decreases IL-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma. Int. J. Cancer 136 (11), 2556\u20132565. 10.1002/ijc.29305", "ArticleIdList": ["10.1002/ijc.29305", "25370454"]}, {"Citation": "Zhao J., Xu B., Xiong Q., Feng Y., Du H. (2021). Erastin-induced ferroptosis causes physiological and pathological changes in healthy tissues of mice. Mol. Med. Rep. 24 (4), 713. 10.3892/mmr.2021.12352", "ArticleIdList": ["10.3892/mmr.2021.12352", "PMC8383038", "34396451"]}, {"Citation": "Zhao X., Wang X., Pang Y. (2022). Phytochemicals targeting ferroptosis: therapeutic opportunities and prospects for treating breast cancer. Pharm. (Basel, Switz. 15 (11), 1360. 10.3390/ph15111360", "ArticleIdList": ["10.3390/ph15111360", "PMC9693149", "36355532"]}, {"Citation": "Zhao Y., Li Y., Zhang R., Wang F., Wang T., Jiao Y. (2020). The role of erastin in ferroptosis and its prospects in cancer therapy. Onco Targets Ther. 13, 5429\u20135441. 10.2147/OTT.S254995", "ArticleIdList": ["10.2147/OTT.S254995", "PMC7295539", "32606760"]}, {"Citation": "Zhou B., Liu J., Kang R., Klionsky D. J., Kroemer G., Tang D. (2020). Ferroptosis is a type of autophagy-dependent cell death. Semin. Cancer Biol. 66, 89\u2013100. 10.1016/j.semcancer.2019.03.002", "ArticleIdList": ["10.1016/j.semcancer.2019.03.002", "30880243"]}, {"Citation": "Zhou X., Wang X., Sun Q., Zhang W., Liu C., Ma W., et al. (2022b). Natural compounds: a new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer. Biomed. Pharmacother. 151, 113096. 10.1016/j.biopha.2022.113096", "ArticleIdList": ["10.1016/j.biopha.2022.113096", "35567987"]}, {"Citation": "Zhou Y., Yang J., Chen C., Li Z., Chen Y., Zhang X., et al. (2021). Polyphyllin \u2162-Induced ferroptosis in MDA-MB-231 triple-negative breast cancer cells can Be protected against by KLF4-mediated upregulation of xCT. Front. Pharmacol. 12, 670224. 10.3389/fphar.2021.670224", "ArticleIdList": ["10.3389/fphar.2021.670224", "PMC8141818", "34040532"]}, {"Citation": "Zhou Y., Zhang J., Guan Q., Tao X., Wang J., Li W. (2022a). The role of ferroptosis in the development of acute and chronic kidney diseases. J. Cell. physiology 237 (12), 4412\u20134427. 10.1002/jcp.30901", "ArticleIdList": ["10.1002/jcp.30901", "36260516"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "6", "Day": "20"}, {"Year": "2023", "Month": "10", "Day": "9"}, {"Year": "2023", "Month": "11", "Day": "3", "Hour": "6", "Minute": "45"}, {"Year": "2023", "Month": "11", "Day": "3", "Hour": "6", "Minute": "44"}, {"Year": "2023", "Month": "11", "Day": "3", "Hour": "3", "Minute": "50"}, {"Year": "2023", "Month": "10", "Day": "18"}], "PublicationStatus": "epublish", "ArticleIdList": ["37920209", "PMC10619677", "10.3389/fphar.2023.1243286", "1243286"]}}], "PubmedBookArticle": []}